RxDoctor Payments Data

Barbara McGuirk

Reproductive Endocrinology · Newark, DENPI 1073578183

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $544, 2.5 times the $215 reported in 2019.

$1,964in general payments, 2019–2025

Across 70 payments — averaging $28.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$403
  • Granata Bio Corporation$360
  • Sumitomo Pharma America, Inc.$270
  • Caldera Medical, Inc$253
  • Pfizer$209
  • EMD Serono, Inc.$158
  • plus $311 from 10 others
$146,545in research payments, 2019–2025

Across 2 payments — averaging $73,273 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • IBSA Institut Biochimique SA$142K
  • AbbVie$5K

What the payments were for

  • Food & beverage$1,964100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few reproductive endocrinology providers in Delawareto place this figure against a meaningful peer group, so we don't.

Other reproductive endocrinology in Newark

Where these figures come from

Is this you, or does something look wrong? →